The stock market was flat during the first half of 2015 due to economic and political uncertainties in Europe and a tumbling energy sector. Yet despite those discouraging facts, some companies were able to deliver an enormous return to their shareholders. Let’s take a closer look at the top five performing stocks in the S&P 500 during the first half of 2015.
Netflix, Inc. (NASDAQ/NFLX), up 92.61%
Netflix, Inc. (NASDAQ/NFLX) rewarded investors magnificently in the first half of 2015. The giant provider of on demand internet streaming media took the attention of many investors as the company increased its revenue and the number of subscriptions in the first half of 2015. The company is serving customers in more than a dozen countries including China and India. The company added an enormous number of most viewer shows and movies such as Friends and Breaking Bad.
Cigna Corp. (NYSE/CI), up 61.99%
Cigna Corp. (NYSE/CI) is one of the top health insurer companies in the U.S. that also performed very well. Over the past few months, Cigna has been in intensified talks with Anthem Inc. over a merger, as part of a consolidation in the health industry.
On Thursday, June 25th, the Supreme Court upheld a key piece of the Obamacare which helps remove a potential obstacle. The news is a victory for the industry, indicating that Cigna’s stock may even go higher.
Skyworks Solutions Inc. (NASDAQ/SWKS), up 52.03%
Skyworks Solutions Inc. (NASDAQ/SWKS) shares have been a winner, up more than 50% year-to-date. Skyworks is a semiconductor company headquartered in Woburn, Massachusetts. With technology experts predicting there will be 70 billion connected devices operating worldwide by 2020, the company seems to continue to increase in its value.
Aenta Inc. (NYSE/AET), up 46.39%
Aetna Inc. (NYSE/AET) looked like another solid company in the health insurer industry. The company has grown significantly and captured a massive portion of market share. Just recently, the second-largest U.S. health insurer by market value announced that it is closing in on an acquisition of Humana Inc. The consolidation in the industry leaves only a few players with a significant number of uninsured applicants.
Hospira Inc. (NYSE/HSP), up 44.65%
Without a doubt, Hospira Inc. (NYSE/HSP) performed remarkably so far this year. The U.S.-based global pharmaceutical and medical device company provides injectable drugs and infusion technologies.
The company has obtained two preapproval inspections and two dozen FDA observations. Injectables specialist Hospira says it has gotten FDA approval and is ramping up production at its new plant in India.